BackAspire Biopharma Holdings Overview

Aspire Biopharma Holdings Common Stock

Aspire Biopharma Holdings's common stock is $17.

Get informed when a big investor buys or sells

+ Follow
Common Stock
$17.00
↓ 99.65% YoYΔ $-4873.00 vs prior year quarter

Peer average / median

Loading

Aspire Biopharma Holdings Common Stock History

Loading

Aspire Biopharma Holdings vs. peers: Common Stock Comparison

Loading

Aspire Biopharma Holdings Common Stock Growth (YoY per quarter)

Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.

Loading

Aspire Biopharma Holdings (ASBP) FAQ

As of the most recent data (March 2026), ASBP shows a common stock of $17. That compares with $4.9K in the prior-year period — down 99.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ASBP's common stock is now $17 (was $4.9K) — a 99.7% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Aspire Biopharma Holdings is outperforming or lagging.

Tracking ASBP's common stock over time shows whether Aspire Biopharma Holdings is scaling, shrinking, or reshaping that part of the business. The current reading is $17 That compares with $4.9K in the prior-year period — down 99.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this common stock page, Stockcircle has Aspire Biopharma Holdings's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $17) with ownership activity and broader fundamentals.